Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age19-29
SponsorNorthern Illinois University

About this trial

The purpose of the present study was to examine the effectiveness of acute A-GPC supplementation on upper and lower body muscular strength, endurance, power, and global levels of activation.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Recreationally-trained males, college-aged

Disqualifiers

If the subjects report: 1) cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders; 2) use of any medications; 3) use of nutritional supplements; 4) habitual use of caffeine (≥1 caffeinated beverage per day); 5) participation in another clinical trial or investigation of another nutritional product within 30 days of screening/enrollment.

Trial design

Design model

Crossover

Treatments tested in this trial

  • L-Alpha glycerylphosphorylcholine

    Dietary supplement

    Oral, 900 mg, single dose study

  • Microcrystalline Cellulose

    Dietary supplement

    Oral, 900 mg, single dose study

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Supplement groupExperimental treatment 1 intervention
Group B: Placebo groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Maximal Voluntary Isometric Contraction

MVIC of leg extensors at 120 degrees between thigh and leg

Time frame
Approximately 90 minutes post-ingestion of condition
2

Muscle Activation

EMG amplitude during MVIC

Time frame
Approximately 90 minutes post ingestion

Secondary outcomes

1

Wingate Anaerobic Test

Peak, mean, minimum power and fatigue index

Time frame
Approximately 100 minutes post-ingestion of condition

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: